Schneider Electric launches programme to increase access to renewable energy for pharmaceutical suppliers Read more
Approval of first interchangeable biosimilar insulin to increase competition with payer contracts: GlobalData Read more
Xeljanz receives marketing authorisation in EU to treat active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis Read more